Prostate cancer is the most common type of cancer in men besides skin cancer. In the U.S., about one in every six or seven men will be diagnosed with prostate cancer in their lifetimes. In Germany, around 67,000 men were diagnosed in 2016, making it the most common malignant tumor in German men.
The good news is that there are several effective treatment options. Radiotherapy and hormone therapy (also called androgen deprivation therapy, or ADT) are two of the most common. Radiotherapy, sometimes combined with ADT, is a standard treatment for prostate cancer.
Deciding which treatment is best can be tricky, and there’s no one-size-fits-all answer. The best approach depends on the individual patient’s risk profile. Sometimes, one is clearly better than the other. In many cases, it’s not so clear.
This article will compare radiation and hormone therapy to help you understand their effectiveness, side effects, and when each might be the better choice. We’ll look at what clinical trials and expert recommendations say about prostate cancer treatment options so you can have a comprehensive overview of your choices. You and your doctor can then decide which is better: radiation or hormone therapy for your prostate cancer.
Read more